This record was last updated September 11, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
To compare the efficacy and safety of capecitabine and cyclophosphamide (XC) versus physician's choice as maintenance therapy for patients with advanced breast cancer who achieved disease control after salvage treatment.
Protocol Amendment History
3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-16; most recent amendment 2025-09-10.
Status change: Not Yet Recruiting → Recruiting2023-11-18